HomeLIPO • NASDAQ
add
Lipella Pharmaceuticals Inc
Previous close
$2.43
Day range
$2.37 - $2.40
Year range
$1.97 - $12.00
Market cap
6.05M USD
Avg Volume
44.08K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 173.67K | 43.71% |
Operating expense | 562.62K | 41.99% |
Net income | -1.44M | -109.28% |
Net profit margin | -830.14 | -45.62% |
Earnings per share | — | — |
EBITDA | -1.45M | -99.02% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.18M | -33.67% |
Total assets | 2.67M | -25.25% |
Total liabilities | 754.42K | 74.34% |
Total equity | 1.92M | — |
Shares outstanding | 2.55M | — |
Price to book | 1.53 | — |
Return on assets | -150.11% | — |
Return on capital | -207.52% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.44M | -109.28% |
Cash from operations | -990.41K | -36.10% |
Cash from investing | — | — |
Cash from financing | 1.82M | 13.03% |
Net change in cash | 831.13K | -5.97% |
Free cash flow | -455.37K | 7.99% |
About
Founded
2005
Headquarters
Website
Employees
5
